Clinical Training:  Hepatitis C

Drs. Paul J. Pockros and Robert J. Fontana, and David R. Nelson

Describe the life cycle if the hepatitis C virus and steps in the cycle that provide good targets for therapeutic intervention; Assess new drugs in development for treatment of hepatitis C; Summarize the natural history of hepatitis C and factors associated with disease progression, morbidity, and mortality; Identify patients with patients C who are at high risk for liver cancer; and Discuss factors associated with recurrence of hepatitis C after liver transplantations.